Company Overview and News

72
How The CARZ ETF Can Help You Hedge The Automobile Trade War

14h seekingalpha
I analyze the effects of this hedging strategy in TSLA, WGO, and GM. GM is directly affected by the trade war, but TSLA and WGO are protected from it.
F GM.WS.A GM.WS.B SPY GM.WS.C TSLA GM DMLRY GM.WSB WGO CARZ

49
Elon Musk’s latest outburst raises doubts on leadership

2018-07-17 business.inquirer.net
In this photo, taken Sept. 29, 2015, Elon Musk, CEO of Tesla Motors Inc., talks about the Model X car at the company’s headquarters, in California. In tweet on Monday, July 3, 2017, Musk announced that the Model 3 car for the masses will go on sale on Friday, July 7. (Photo by MARCIO JOSE SANCHEZ / AP)
TSLA

131
5 Top Stock Trades for Tuesday — Buy Amazon Into Prime Day?

2018-07-16 investorplace
Banks were off to a hot start on Monday amid an otherwise unmemorable performance from U.S. equities. Let’s look at the financial sector first for our top stock trades.
BAC OSTK JPM TSLA NYTAB

51
Tesla Q3: $6B Sales, Top 20 U.S. Car, And Path To Shanghai With $12B To Pay For Factories

2018-07-16 seekingalpha
Tesla just signed a memorandum of intent with Shanghai to build a 500k EV per year Gigafactory 3 in China = ~$20B/yr revenue.
TSLA

54
Talend: A Big Data Disruptor

2018-07-15 seekingalpha
Talend is a software company in the data integration space that has been disrupting legacy providers.
IBM MDB TSLA CRM TLND

52
Weighing The Week Ahead: Anything Goes!

2018-07-15 seekingalpha
The week ahead is loaded with big stories about the economy, earnings, the Fed, D.C. controversy, trade issues, and the Trump/Putin summit.
LMT MS.PRE MS.PRF MS.PRG MS.PRA NOC MS.PRI SWK MS.PRK TSLA MS DAL

63
Tesla (TSLA) Stock Hits 200K Cars, Loses Half of Buyer Tax Credits | InvestorPlace

2018-07-13 investorplace
Tesla (NASDAQ:TSLA) has hit a major milestone, by delivering 200,000 electric cars to U.S. customers. That’s obviously good news for the company and TSLA stock investors. However, that success comes with a downside.
GM.WS.A GM.WS.B GM.WS.C TSLA GM GM.WSB

72
Tesla Inc Whistleblower Continues to Rile Musk

2018-07-13 investorplace
Martin Tripp, a former employee of Tesla Inc (NASDAQ:TSLA), is not backing down. His latest move: A filing of a whistleblower complaint with the Securities and Exchange Commission.
FB JPM MON TSLA SNAP

50
Tesla May Be Seeing Limited Demand For Its Current Production

2018-07-13 seekingalpha
Two weeks ago, Tesla opened up Model 3 orders to all US and Canada-based reservation holders.
TSLA

116
China Blinked - Cramer's Mad Money (7/12/18)

2018-07-13 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, July 12.
APC FB CHDN MA NFLX AXP GOOG VICI SAGE V AMZN JNJ AAPL TSLA KSS PENN AEUA BYD

49
Tesla CEO Elon Musk Might Come to India in 2019

2018-07-13 moneycontrol
Although Tesla cars coming to India is still uncertain, CEO of Tesla, Elon Musk might be making to trip to India in 2019. Musk just recently spent three days in China, looking to plan out Tesla’s operations in the country.
TSLA

85
Podcast 18: Boots On The Ground With Rob Carrick

2018-07-13 seekingalpha
On episode 18 of the podcast, I'm joined by The Globe and Mail's Rob Carrick, who I think is the top personal finance journalist in Canada.
AMZN TSLA

50
Model 3 Backlog Conversion Ratio At 30% Challenges Tesla's Growth Narrative

2018-07-13 seekingalpha
At that conversion ratio, the current 420,000 backlog translates into 126,000 deliveries and only 36,000 vehicles at the current ASP.
TSLA

65
Tesla’s Federal Tax Credit Gets Halved in January

2018-07-12 247wallst
Electric carmaker Tesla Inc. (NASDAQ: TSLA) hit a milestone this month. The company sold its 200,000th vehicle, an achievement that is both sweet and bitter.
GM.WS.A GM.WS.B GM.WS.C TSLA GM GM.WSB

49
How the Tesla Model 3 Will Finally Reach the Masses | InvestorPlace

2018-07-12 investorplace
At the end of June, Tesla (NASDAQ:TSLA) hit a major milestone. While the TSLA stock price didn’t reflect it, producing 5,000 Tesla Model 3 vehicles in a week was a big accomplishment for the company. But is the new sedan for the masses yet? It’s getting there.
TSLA NYTAB

TSLA : Tesla Motors Stock Analysis and Research Report

2017-10-09 - Asif

Tesla Motors's mission is to accelerate the world’s transition to sustainable energy. The company design, develop, manufacture, lease and sell high-performance fully electric vehicles, solar energy generation systems and energy storage products. The company also offer maintenance, installation, operation and other services related to its products. Automotive Tesla Motors production vehicle fleet includes Model S premium sedan and Model X sport utility vehicle, which are its highest-performance and most capable vehicles, and beginning in July 2017, its Model 3, a lower priced sedan designed for the mass market. The company continue to enhance its vehicle offerings with enhanced Autopilot options, Internet connectivity and free over-the-air software updates. The company continually deploy its internally developed software into the vehicle fleet, depending on the hardware of the vehicle, to provide additional safety and convenience features. The company are also actively working ...

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

21h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

23h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to TSLA / Tesla Motors, Inc. on message board site Silicon Investor.

Tesla EVs - TSLA WTSLA: Wet Seal, Inc.
CUSIP: 88160R101